Cons Of 'Brexit' For Pharma Could Far Outweigh Pros
Executive Summary
The pharma and health policy consequences of a possible "Brexit" – i.e. the departure of the U.K. from the European Union – were discussed by a variety of stakeholders earlier this month. The U.K.'s recent general gave Prime Minister David Cameron a mandate to hold an EU referendum by the end of 2017.